Long Covid Research,
what lands in your inbox each week:
- 📚7 fresh studies
- 📝plain-language summaries
- ✅direct links to original studies
- 🏅top journal indicators
- 📅weekly delivery
- 🧘♂️always free
some of our latest newsletters:
(select one to read it below)
Long COVID hits younger adults harder than expected—unless they have chronic diseases
This week brought surprising insights about who's really at risk for long COVID, plus new clues about the biological mechanisms keeping symptoms alive months after infection.
🔄 The Age Paradox: Why Being Young Doesn't Protect Against Long COVID
A massive study of 133,792 COVID patients found that each decade of age actually decreased long COVID odds by 6%—but only after accounting for chronic diseases
The twist: chronic conditions like diabetes and heart disease accounted for 145% of age's apparent harm, meaning age itself is protective until around 65
Adults under 65 retained strong biological resilience against long COVID independent of their health conditions, while those over 65 lost this protective advantage entirely
Why it matters: Risk assessment should focus on underlying health conditions rather than birth year for younger adults—a 30-year-old with diabetes may face higher long COVID risk than a healthy 50-year-old.
Key Findings
🧠 Long COVID Symptoms Fade to Normal Levels Within a Year
At 1 month post-infection, 44% of 14,964 adults reported physical symptoms, 47% had mental health issues, and 33% experienced cognitive problems
By 12 months, symptom rates dropped to match uninfected controls across most categories
Four persistent symptom clusters remained: loss of taste/smell, respiratory issues, brain fog, and psychosocial symptoms
🔬 Quantum Computing Uncovers New Long COVID Targets
Researchers used quantum walk algorithms to analyze protein networks affected by SARS-CoV-2, identifying deeper connections than traditional methods
The analysis pinpointed mitochondrial dysfunction, blood clotting inflammation, and brain inflammation as central mechanisms
VDAC1, a mitochondrial calcium transporter, emerged as a potential therapeutic target, with FDA-approved cannabidiol showing promise
🩺 Genitourinary Problems May Be Long COVID's Hidden Symptom Set
A meta-analysis of 2,332 participants found menstrual disorders in 49% of women, erectile dysfunction in 21% of men, and kidney function decline in 29% overall
These symptoms persisted 12+ weeks after infection across nine studies from eight countries
Most studies showed low risk of bias, suggesting these aren't just coincidental findings
🧪 Immune System Stays Hyperactive Years After COVID
Blood analysis of 92 people with long COVID (average 34 months post-infection) revealed 26 proteins with abnormal levels compared to controls
The most elevated were Oncostatin M and IL-1 receptor antagonist, along with multiple inflammatory markers like IL-6 and IL-12B
Spike protein levels were normal, suggesting inflammation persists independently of ongoing viral replication
💊 Anti-Inflammatory Drugs May Prevent Long COVID Deaths
Among 3,553 rheumatoid arthritis patients, those prescribed IL-6 receptor blockers (sarilumab or tocilizumab) had 60% lower mortality and 58% fewer long COVID diagnoses over 12 months
The protective effect was compared to other biologic drugs like anakinra or baricitinib
Results suggest IL-6 inflammation may be a key driver of severe long COVID outcomes
🫁 Virtual Reality Shows Promise for Long COVID Rehabilitation
Nine randomized trials with 552 patients (488 COPD, 64 post-COVID) tested VR-based pulmonary rehabilitation against standard programs
All studies showed exercise capacity improvements, with several finding greater gains in VR groups
VR participants also showed better reductions in anxiety and depression scores compared to traditional rehabilitation
Implications
This week's research reveals long COVID as a complex interplay between biological resilience, chronic disease burden, and persistent immune dysfunction. While most symptoms may resolve within a year, targeted interventions—from anti-inflammatory drugs to VR rehabilitation—could help the substantial minority who develop lasting complications.
Science is the only real news.
The rest is just drama 📰
And nowadays, we see that drama everywhere.
Drama sells ads, ads sell products, and my attention sells to the highest bidder.
Drama media is junk food for the mind.
A quick rush, hard to avoid, but little nutritional value.
The brain wants broccoli 🧠🥦
And look, it's not that science never makes the news.
But think about when it does—does the news really understand the science it reports on?
Like it or not, AI exists now.
And it happens to be a huge science nerd… 🔭🤖
…with a superpower…
...unlike an average science nerd, AI can explain it simply.
I built OpenScience to make the constant stream of new studies accessible to anyone.
To free science from academic jargon and tiny-fonted PDFs.
OpenScience is a weekly newsletter of 7 compelling studies from the past week in the topic of your choice.
Made simple, digestible, and delightful by AI.
Interested in CRISPR?
The latest Long Covid research?
Psychedelic medicine?
Follow the actual science, as it comes out.
Every study is linked to the original PubMed so you can verify the AI's summary yourself.
Pick a topic, get the weekly email, and give your mind the broccoli it deserves 🥦
The real-time unfolding of science is too interesting not to follow.